In silicoanalysis of protein/peptide-based inhalers against SARS-CoV-2

被引：3
|
作者：
Salman, Saad [1 ]
Shah, Fahad Hassan [2 ]
Chaudhry, Maham [1 ]
Tariq, Muniba [3 ]
Akbar, Muhammad Yasir [4 ]
Adnan, Muhammad [1 ]
机构：
[1] Univ Lahore, Dept Pharm, Islamabad Campus, Islamabad 44000, Federal, Pakistan
[2] Univ Peshawar, Ctr Biotechnol & Microbiol, Khyber Pakhtunkhwa, Pakistan
[3] Univ Lahore, Diet & Nutr Sci, Islamabad Campus, Islamabad 44000, Federal, Pakistan
[4] Quaid i Azam Univ, Dept Bioinformat, Islamabad 44000, Federal, Pakistan
来源：
FUTURE VIROLOGY | 2020年 / 15卷 / 09期
关键词：
COVID-19; dornase-alfa; inhalers; monoclonal antibody; short-palate-lung and nasal-epithelial clone-1-derived peptides; DELIVERY; LUNG;
D O I：
10.2217/fvl-2020-0119
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Aim:Peptide/protein-based inhalers are excessively used to treat respiratory disorders. The molecular docking was performed for these inhalers including human neutralizing S230 light chain-antibody (monoclonal antibodies [mAbs]), alpha-1-antitrypsin (AAT), short-palate-lung and nasal-epithelial clone-1-derived peptides (SPLUNC1) and dornase-alfa (DA) against spike glycoprotein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to assess their inhibitory activity.Materials & methods:HawkDock was used to dock these biologics against SARS-CoV-2 spike-glycoprotein.Results:Results showed that DA, AAT and mAb were quite active against spike glycoprotein with a binding free energy of -26.35 and -22.94 kcal/mol.Conclusion:mAB and AAT combined with DA can be used in the treatment of coronavirus disease of 2019 as a potential anti-SARS-CoV-2 agent.
引用
收藏
页码：557 / 564
页数：8
相关论文
共 50 条
  • [21] Peptide-based direct electrochemical detection of receptor binding domains of SARS-CoV-2 spike protein in pristine samples
    Kumar, T. H. Vignesh
    Srinivasan, Sowmiya
    Krishnan, Vinoth
    Vaidyanathan, Rama
    Babu, Kannadasan Anand
    Natarajan, Sudhakar
    Veerapandian, Murugan
    SENSORS AND ACTUATORS B-CHEMICAL, 2023, 377
  • [22] Computational Design of a Potential Therapeutic Peptide Against Spike Protein of SARS-CoV-2
    Alibakhshi, Abbas
    Ahangarzadeh, Shahrzad
    Beikmohammadi, Leila
    Soltanmohammadi, Behnoush
    Bahrami, Armina Alagheband
    Ranjbar, Mohammad Mehdi
    Mohammadi, Elmira
    JOURNAL OF COMPUTATIONAL BIOPHYSICS AND CHEMISTRY, 2021, 20 (04): : 337 - 346
  • [23] In Silico Design of Peptide-Based SARS-CoV-2 Fusion Inhibitors That Target WT and Mutant Versions of SARS-CoV-2 HR1 Domains
    Stoddard, Shana V.
    Wallace, Felissa E.
    Stoddard, Serena D.
    Cheng, Qianyi
    Acosta, Daniel
    Barzani, Shaliz
    Bobay, Marissa
    Briant, Jared
    Cisneros, Christian
    Feinstein, Samantha
    Glasper, Kelsey
    Hussain, Munazza
    Lidoski, Abigail
    Lingareddy, Pranay
    Lovett, Grace
    Matherne, Leslie
    Mcintosh, Jackson
    Moosani, Nikita
    Nagge, Lia
    Nyamkondiwa, Kudzai
    Pratt, Isaiah
    Root, Emma
    Rutledge, Mary Rose
    Sawyer, Mackenzie
    Singh, Yash
    Smith, Kristiana
    Tanveer, Ubaid
    Vaghela, Sona
    BIOPHYSICA, 2021, 1 (03): : 311 - 327
  • [24] Repurposing fusion inhibitor peptide against SARS-CoV-2
    Efaz, Faiyaz Md.
    Islam, Shafiqul
    Talukder, Shafi Ahmad
    Akter, Shaila
    Tashrif, Md. Zakaria
    Ali, Md. Ackas
    Sufian, Md. Abu
    Parves, Md. Rimon
    Islam, Md. Jahirul
    Halim, Mohammad A.
    JOURNAL OF COMPUTATIONAL CHEMISTRY, 2021, 42 (32) : 2283 - 2293
  • [25] Carotane sesquiterpenes fromFerula vesceritensis:in silicoanalysis as SARS-CoV-2 binding inhibitors
    Mohamed, Tarik A.
    Elshamy, Abdelsamed, I
    Ibrahim, Mahmoud A. A.
    Zellagui, Ammar
    Moustafa, Mahmoud F.
    Abdelrahman, Alaa H. M.
    Ohta, Shinji
    Pare, Paul W.
    Hegazy, Mohamed-Elamir F.
    RSC ADVANCES, 2020, 10 (57) : 34541 - 34548
  • [26] A Dynamic and Effective Peptide-Based Strategy for Promptly Addressing Emerging SARS-CoV-2 Variants of Concern
    Murdocca, Michela
    Romeo, Isabella
    Citro, Gennaro
    Latini, Andrea
    Centofanti, Federica
    Bugatti, Antonella
    Caccuri, Francesca
    Caruso, Arnaldo
    Ortuso, Francesco
    Alcaro, Stefano
    Sangiuolo, Federica
    Novelli, Giuseppe
    PHARMACEUTICALS, 2024, 17 (07)
  • [27] Potential Immunogenic Activity of Computationally Designed mRNA- and Peptide-Based Prophylactic Vaccines against MERS, SARS-CoV, and SARS-CoV-2: A Reverse Vaccinology Approach
    Khan, Taimoor
    Khan, Abbas
    Ansari, Jawad Khaliq
    Najmi, Muzammil Hasan
    Wei, Dong-Qing
    Muhammad, Khalid
    Waheed, Yasir
    MOLECULES, 2022, 27 (07):
  • [28] Immunoinformatics Approach for the Identification and Characterization of T Cell and B Cell Epitopes towards the Peptide-Based Vaccine against SARS-CoV-2
    Chakraborty, Chiranjib
    Sharma, Ashish Ranjan
    Bhattacharya, Manoji
    Sharma, Garima
    Lee, Sang-Soo
    ARCHIVES OF MEDICAL RESEARCH, 2021, 52 (04) : 362 - 370
  • [29] Designing a multi-epitope peptide based vaccine against SARS-CoV-2
    Singh, Abhishek
    Thakur, Mukesh
    Sharma, Lalit Kumar
    Chandra, Kailash
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [30] Designing a multi-epitope peptide based vaccine against SARS-CoV-2
    Abhishek Singh
    Mukesh Thakur
    Lalit Kumar Sharma
    Kailash Chandra
    Scientific Reports, 10
12345